Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download Table Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2017
(Whole Dollars)
Research Category Amount
Network for Direct Patient Engagement     $19,999,626
Cancer Immunotherapy Translational Science Network     $34,011,598
Therapeutic Target Identification to Overcome Drug Resistance    

$14,336,865

A National Cancer Data Ecosystem for Sharing and Analysis    

$11,572,741

Fusion Oncoproteins in Childhood Cancers    

$1,733,623

Prevention and early detection: Implementation of Evidence-Based Approaches

$28,245,612

Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care

$12,889,396

Generation of Human Tumor Atlases

$37,327,764

Development of New Enabling Cancer Technologies

$62,948,903

Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)

$53,618,708

Subtotal, Research Category

$276,684,836

Fiscal Year 2017 Carryover

$23,315,164

Total
$300,000,000

  • Posted: February 16, 2018